Thorne HealthTech Balance Sheet Health
Financial Health criteria checks 5/6
Thorne HealthTech has a total shareholder equity of $155.3M and total debt of $25.0M, which brings its debt-to-equity ratio to 16.1%. Its total assets and total liabilities are $282.5M and $127.3M respectively. Thorne HealthTech's EBIT is $14.0M making its interest coverage ratio 14.8. It has cash and short-term investments of $17.1M.
Key information
16.1%
Debt to equity ratio
US$24.99m
Debt
| Interest coverage ratio | 14.8x |
| Cash | US$17.09m |
| Equity | US$155.26m |
| Total liabilities | US$127.27m |
| Total assets | US$282.53m |
Recent financial health updates
Recent updates
Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 12
Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar
Jun 07Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist
Dec 17Thorne HealthTech Grows But Faces Macro Headwinds
Sep 09Thorne HealthTech's blood collection device OneDraw gets clearance in Japan
Aug 23Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised
Aug 09Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies
Jun 05Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality
Mar 23Thorne HealthTech: Good Potential At A Low Price
Jan 11Financial Position Analysis
Short Term Liabilities: THRN's short term assets ($135.5M) exceed its short term liabilities ($56.2M).
Long Term Liabilities: THRN's short term assets ($135.5M) exceed its long term liabilities ($71.0M).
Debt to Equity History and Analysis
Debt Level: THRN's net debt to equity ratio (5.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if THRN's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: THRN's debt is well covered by operating cash flow (86.1%).
Interest Coverage: THRN's interest payments on its debt are well covered by EBIT (14.8x coverage).